Revisiting reactive arthritis during the COVID-19 pandemic.

Bekaryssova, Dana; Yessirkepov, Marlen; Zimba, Olena; Gasparyan, Armen Yuri; Ahmed, Sakir

Bekaryssova, Dana; Yessirkepov, Marlen; Zimba, Olena; Gasparyan, Armen Yuri; Ahmed, Sakir.

Bekaryssova D; Department of Biology and Biochemistry, South Kazakhstan Medical Academy, Shymkent, Kazakhstan.
Yessirkepov M; Department of Biology and Biochemistry, South Kazakhstan Medical Academy, Shymkent, Kazakhstan.
Zimba O; Department of Internal Medicine #2, Danylo Halytsky Lviv National Medical University, Lviv, Ukraine.
Gasparyan AY; Departments of Rheumatology and Research and Development, Dudley Group NHS Foundation Trust (Teaching Trust of the University of Birmingham, UK), Russells Hall Hospital, Dudley, West Midlands, UK.
Ahmed S; Department of Clinical Immunology and Rheumatology, Kalinga Institute of Medical Sciences (KIMS), KIIT University, Bhubaneswar, 751024, India. sakir005@gmail.com.

Clin Rheumatol ; 41(8): 2611-2612, 2022 08.

Article in English | MEDLINE | ID: covidwho-1919809

Subject(s)

Arthritis, Reactive; COVID-19; Arthritis, Reactive/epidemiology; Humans; Pandemics; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Arthritis, Reactive / COVID-19 Type of study: Observational study Topics: Long Covid Limits: Humans Language: English Journal: Clin Rheumatol Year: 2022 Document Type: Article Affiliation country: S10067-022-06252-6

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google